Literature DB >> 15077286

Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?

Dinesh Khanna1, Maureen McMahon, Daniel E Furst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15077286     DOI： 10.1002/art.20164

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  28 in total

1.  Long term safety of etanercept in elderly subjects with rheumatic diseases.

Authors:  R Fleischmann; S W Baumgartner; M H Weisman; T Liu; B White; P Peloso
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Renal-Specific Silencing of TNF (Tumor Necrosis Factor) Unmasks Salt-Dependent Increases in Blood Pressure via an NKCC2A (Na+-K+-2Cl- Cotransporter Isoform A)-Dependent Mechanism.

Authors:  Shoujin Hao; Mary Hao; Nicholas R Ferreri
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 4.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 5.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

Review 6.  Update of TNF-alpha antagonists and cardiovascular disease in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Agustín Escalante
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

7.  Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.

Authors:  Timothy D Bryson; Xiaosong Gu; Remonda M Khalil; Safa Khan; Liping Zhu; Jiang Xu; Edward Peterson; Xiao-Ping Yang; Pamela Harding
Journal:  J Mol Cell Cardiol       Date:  2018-03-06       Impact factor: 5.000

Review 8.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 9.  Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.

Authors:  Ivica Lazúrová; Ľubomír Tomáš
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

10.  Update on the use of etanercept across a spectrum of rheumatoid disorders.

Authors:  Bernard Combe
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.